Skip to content
healthcare.dev

Lamivudine and Zidovudine

NDC 33342-003, Lamivudine and Zidovudine, tablet, from Macleods Pharmaceuticals Limited.

Product NDC
33342-003
Status
Listed
Labeler
Macleods Pharmaceuticals Limited
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA090679
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/33342-003 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LAMIVUDINE150 mg/1
  • ZIDOVUDINE300 mg/1

Pharmacologic classes

Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Nucleoside Reverse Transcriptase Inhibitors [MoA]; Nucleoside Reverse Transcriptase Inhibitors [MoA]

Package NDCNDC-11Package
33342-003-093334200030960 TABLET in 1 BOTTLE (33342-003-09)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/63667952-be01-483e-9887-1d5417e7ec16
  • NADAC price for package 33342000309

    GET /v1/drugs/nadac/33342000309

Use it

Look up 33342-003 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/33342-003 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 33342-003. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.